Nabriva Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference Sep 25, 2018 07:00AM
Cantor Fitzgerald Maintains OW, $16 PT on Nabriva (NBRV) Following Phase 3 Data For Oral Lefamulin May 21, 2018 08:47AM
Nabriva Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights May 8, 2018 07:00AM
Nabriva Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference Sep 20, 2017 05:22PM
Pre-Open Stock Movers 09/20: (ALNY) (KPTI) (GEMP) Higher; (BBBY) (IONS) (GIS) Lower (more...) Sep 20, 2017 09:29AM


Sep 18, 2017 09:07AM Nabriva (NBRV): Shares Up 100% On LEAP 1 Data - Cantor
Jun 22, 2017 04:34PM Cantor Fitzgerald Assumes Nabriva Therapeutics AG (NBRV) at Overweight
Feb 17, 2017 07:15AM Nabriva (NBRV): Initiating with Overweight - Cantor Fitzgerald
Dec 19, 2016 04:13PM Nabriva Announces Closing of Rights Offering and Underwritten Offering
Dec 14, 2016 06:57PM Nabriva Announces Results of Rights Offering and Pricing of Underwritten Offering
Nov 29, 2016 04:00PM Nabriva Announces Terms of Rights Offering
Jul 5, 2016 07:00AM Nabriva to Present at Cantor Fitzgerald's 2nd Annual Healthcare Conference